Modest opioid withdrawal suppression efficacy of oral tramadol in humans

Psychopharmacology

Volumn 194, Issue 3, 2007, Pages 381-393

  Lofwall, Michelle R ^a,b   Walsh, Sharon L ^a,b   Bigelow, George E ^a   Strain, Eric C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Human; Morphine; Naloxone; Opioid dependence; Opioid withdrawal; Tramadol

Indexed keywords

MORPHINE; NALOXONE; OPIATE; TRAMADOL;

ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE;

ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; COGNITION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PSYCHOMOTOR PERFORMANCE; SUBSTANCE WITHDRAWAL SYNDROME; TRAMADOL;

EID: 34548591189     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0847-3     Document Type: Article

References (55)

1. Balster RL, Bigelow GE (2003) Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend 70:S13-S40
2. Barann M, Urban B, Stamer U, Dorner Z, Bonisch H, Bruss M (2006) Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis. Eur J Pharmacol 531:54-58
3. Barth H, Durra S, Giertz H, Goroll D, Flohe L (1987) Long-term administration of the centrally acting analgesic tramadol did not induce dependence or tolerance. Pain 4:S231
4. Berrocoso E, Mico JA, Ugedo L (2006) In vivo effect of tramadol on locus coeruleus neurons is mediated by alpha2-adrenoceptors and modulated by serotonin. Neuropharmacology 51:146-153
5. Bodalia B, McDonald CJ, Smith KJ, O'Brien C, Cousens L (2003) A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules. J Pain Symptom Manage 25:142-149
6. Cami J, Lamas X, Farre M (1994) Acute effects of tramadol in methadone-maintained volunteers. Drugs 47(Suppl 1):39-43
7. Carroll CP, Walsh SL, Bigelow GE, Strain EC, Preston KL (2006) Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans. Exp Clin Psychopharmacol 14:109-120
8. Cicero TJ, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, Senay EC, Woody GE (1999) A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend 57:7-22
9. Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE, Munoz A (2005) Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf 14:851-859
10. Collart L, Luthy C, Favario-Constantin C, Dayer P (1993) Duality of the analgesic effect of tramadol in humans. Schweiz Med Wochenschr 123:2241-2243
11. Collins ED, Kleber HD, Whittington RA, Heitler NE (2005) Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA 294:903-913
12. Desmeules JA, Piguet V, Collart L, Dayer P (1996) Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 41:7-12
13. Enggaard TP, Poulsen L, Arendt-Nielsen L, Brosen K, Ossig J, Sindrup SH (2006) The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6. Anesth Analg 102:146-150
14. Epstein DH, Preston KL, Jasinski DR (2006) Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol 73:90-99
15. Fliegert F, Kurth B, Gohler K (2005) The effects of tramadol on static and dynamic pupillometry in healthy subjects-the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status. Eur J Clin Pharmacol 61:257-266
16. Fraser HF, Isbell H, Vanhorn GD (1960) Human pharmacology and addiction liability of norcodeine. J Pharmacol Exp Ther 129:172-177
17. Fraser HF, Rosenberg DE (1964) Studies on the human addiction liability of 2¢-hydroxy-5-9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan (Win 20,228): a weak narcotic antagonist. J Pharmacol Exp Ther 143:149-156
18. Friderichs E, Felgenhauer F, Jongschaap P, Osterloh G (1978) Pharmacological studies on analgesia, dependence on and tolerance of tramadol, a potent analgetic drug (author's transl). Arzneimittelforschung 28:122-134
19. Frink MC, Hennies HH, Englberger W, Haurand M, Wilffert B (1996) Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung 46:1029-1036
20. Gillen C, Haurand M, Kobelt DJ, Wnendt S (2000) Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedeberg's Arch Pharmacol 362:116-121
21. Griffiths RR, Bigelow GE, Liebson I (1983) Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry 40:865-873
22. Gutstein H, Akil H (2001) Opioid analgesics. In: Hardman J, Limbird L, Gilman A (eds) Goodman and Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 569-619
23. Hennies HH, Friderichs E, Schneider J (1988) Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 38:877-880
24. Inciardi JA, Cicero TJ, Munoz A, Adams EH, Geller A, Senay EC, Woody GE (2006) The Diversion of Ultram, Ultracet, and generic tramadol HCL. J Addict Dis 25:53-58
25. Jasinski DR (1977) Assessment of the abuse potentiality of morphinelike drugs (methods used in man). In: Martin WR (ed) Drug addiction I. Springer, Berlin, pp 197-258
26. Jasinski DR, Griffith JD, Carr CB (1975) Etorphine in man. I. Subjective effects and suppression of morphine abstinence. Clin Pharmacol Ther 17:267-272
27. Jasinski DR, Martin WR, Hoeldtke R (1971) Studies of the dependence-producing properties of GPA-1657, profadol, and propiram in man. Clin Pharmacol Ther 12:613-649
28. Jasinski DR, Preston KL, Sullivan JT, Testa M (1993) Abuse potential of oral tramadol. NIDA Res Monogr 132:103
29. Knaggs RD, Crighton IM, Cobby TF, Fletcher AJ, Hobbs GJ (2004) The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers. Anesth Analg 99:108-112
30. Kolb L, Himmelsbach CK (1938) Clinical studies of drug addiction. III. A critical review of the withdrawal treatments with method of evaluating abstinence syndromes. Am J Psychiatry 94:759-797
31. Lai J, Ma SW, Porreca F, Raffa RB (1996) Tramadol, M1 metabolite and enantiomer affinities for cloned human opioid receptors expressed in transfected HN9.10 neuroblastoma cells. Eur J Pharmacol 316:369-372
32. Lehmann KA, Kratzenberg U, Schroeder-Bark B, Horrichs-Haermeyer G (1990) Postoperative patient-controlled analgesia with tramadol: analgesic efficacy and minimum effective concentrations. Clin J Pain 6:212-220
33. McLeod D, Griffiths RR, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum Comput 14:463-466
34. Murano T, Yamamoto H, Endo N, Kudo Y, Okada N, Masuda Y, Yano I (1978) Studies on dependence on tramadol in rats. Arzneimittelforschung 28:152-158
35. Preston KL, Jasinski DR (1989) Effects of tramadol in humans: assessment of its abuse potential. NIDA Res Monogr 95:392
36. Preston KL, Jasinski DR, Testa M (1991) Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 27:7-17
37. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL (1992) Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 260:275-285
38. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, Jacoby HI, Selve N (1993) Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 267:331-340
39. Reitan R (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271-276
40. Rouini MR, Ardakani YH, Soltani F, Aboul-Enein HY, Foroumadi A (2006) Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. J Chromatogr B 830:207-211
41. Salehi M, Amanatkar M, Barekatain M (2005) Tramadol versus methadone for the management of acute opioid withdrawal: an add-on study. J Res Med Sci 11:185-189
42. Schatzberg A, Cole J, DeBattista C (1997) Manual of clinical psychopharmacology, 3rd edn. American Psychiatric, Washington, DC
43. Senay EC, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH, Woody GE, Cicero TJ (2003) Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 69:233-241
44. Singewald N, Philippu A (1998) Release of neurotransmitters in the locus coeruleus. Prog Neurobiol 56:237-267
45. Sobey PW, Parran TV Jr, Grey SF, Adelman CL, Yu J (2003) The use of tramadol for acute heroin withdrawal: a comparison to clonidine. J Addict Dis 22:13-25
46. Spitzer RL, Williams JB, Gibbon M, First MB (1992) The structured clinical interview for DSM-III-R (SCID). I. History, rationale, and description. Arch Gen Psychiatry 49:624-629
47. Stoller KB, Bigelow GE, Walsh SL, Strain EC (2001) Effects of buprenorphine/naloxone in opioid-dependent humans. Psychopharmacology (Berl) 154:230-242
48. Strain EC, Stoller K, Walsh SL, Bigelow GE (2000) Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology (Berl) 148:374-383
49. Tamaskar R, Parran TV Jr, Heggi A, Brateanu A, Rabb M, Yu J (2003) Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study. J Addict Dis 22:5-12
50. Threlkeld M, Parran TV, Adelman CA, Grey SF, Yu J (2006) Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study. Am J Addict 15:186-191
51. Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL (2003) Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend 69:263-272
52. Walsh SL, Strain EC, Bigelow GE (2003) Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans. Addiction 98:427-439
53. Woody GE, Senay EC, Geller A, Adams EH, Inciardi JA, Schnoll S, Munoz A, Cicero TJ (2003) An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride). Drug Alcohol Depend 72:163-168
54. Yanagita T (1978) Drug dependence potential of 1-(m-methoxyphenyl)-2- dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys. Arzneimittelforschung 28:158-163
55. Zacny JP (2005) Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users. Drug Alcohol Depend 80:273-278